Inviting you to 1st PV Class

In the new "Drug Administration Law" in 2019, establishing a pharmacovigilance system is required for the first time in China. The second paragraph of its Article 12 stipulates: "The state should establish a pharmacovigilance system to monitor, identify, evaluate and control adverse drug reactions and other adverse drug-related reactions."

In order to meet the needs of our members, CQAF PV sub-committee is going to launch the 1st Pharmacovigilance On-line Class on 11Dec (13:30-15:30) . On the Class, the PV experts will bring us PV related China regulation and law and their requirements as well as the PV inspection landscape. We will also share the US/EU PV inspection finding trending on the Class. We are looking forward to your registration of the class!

2019年新颁布的《药品管理法》中，我国首次规定了药物警戒制度。其第十二条第二款规定：“国家建立药物警戒制度，对药品不良反应及其他与用药有关的有害反应进行监测、识别、评估和控制”。

为满足大家对于PV相关知识了解的要求，CQAF PV Sub-committee将于12月11日（13:30-15:30）在线上推出第一期PV小课堂。我们特邀PV专家为大家讲述“PV相关法律法规和要求，药物警戒检查概览”以及“欧美PV检查发现的年度报告趋势”。期待大家的注册！

-------------------------------------------------------------------------------------------------------------

Please register the class before Nov. 30, 2020. 请在11月30日前注册会议。

如何注册会议：

•注册会议前，请确保您已注册成为CQAF会员，且处于有效期内，如何注册会员，请参照 CQAF Website User Guide 

•点击本页面右上方sign up注册会议，注明您具体参与会场或是网络会议拨入然后点击 Pay，由此CQAF工作人员会根据你提供的信息邮件给您会议详细信息。

了解更多CQAF获益，请参见会员页面。

如有任何问题，请联系我们 Chinaqaforum@gmail.com